UBS Group
XYL icon

UBS Group’s Xylem XYL Stock Holding History

UBS Group’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52M Buy
38,264
+19,700
+106% +$2.27M ﹤0.01% 4270
2026
Q1 		$2.22M Sell
18,564
-1,400
-7% -$184K ﹤0.01% 4879
2025
Q4 		$2.72M Sell
19,964
-25,682
-56% -$3.69M ﹤0.01% 4672
2025
Q3 		$6.73M Hold
45,646
– – ﹤0.01% 3726
2025
Q2 		$5.9M Sell
45,646
-3,600
-7% -$436K ﹤0.01% 3707
2025
Q1 		$5.88M Buy
49,246
+3,600
+8% +$446K ﹤0.01% 3616
2024
Q4 		$5.3M Hold
45,646
– – ﹤0.01% 3787
2024
Q3 		$6.16M Hold
45,646
– – ﹤0.01% 2855
2024
Q2 		$6.19M Buy
45,646
+18,564
+69% +$2.53M ﹤0.01% 2645
2024
Q1 		$3.5M Buy
+27,082
New +$3.27M ﹤0.01% 3359
2015
Q2 		– Sell
-300
Closed -$11K – 8892
2015
Q1 		$11K Sell
300
-2,200
-88% -$77.6K ﹤0.01% 7578
2014
Q4 		$95K Buy
+2,500
New +$91.4K ﹤0.01% 5755

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

UBS Group's XYL Position: Q2 2026 in Review

UBS Group increased its Xylem (XYL) stake by 33% in Q2 2026, buying an estimated $41.3M and bringing the position to 1,433,166 shares worth $169M. The position accounts for 0.02% of the portfolio, ranked #766.

UBS Group first reported a position in XYL in Q4 2014 and has held it in 47 quarters since. The position peaked at $235M in Q4 2024. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • UBS Group held 1,433,166 shares of Xylem worth $169M as of Q2 2026.
  • UBS Group bought 358,083 Xylem shares in Q2 2026, an estimated $41.3M.
  • Xylem made up 0.02% of UBS Group's portfolio in Q2 2026, its #766 holding.
  • UBS Group first reported a position in Xylem in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Xylem position peaked at $235M in Q4 2024.
  • 1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.